Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: A multicenter, randomized, parallel-group, double-blind pharmacodynamic study

Digestive Diseases and Sciences

Volumn 56, Issue 8, 2011, Pages 2333-2342

  Ashida, Kiyoshi ^a   Kinoshita, Yoshikazu ^b   Hongo, Michio ^c   Iwakiri, Katsuhiko ^d   Uemura, Naomi ^e   Akiyama, Junichi ^e   Joh, Takashi ^f   Sasaki, Makoto ^f   Kataoka, Hiromi ^f   Wada, Tsuneya ^f   Tanida, Satoshi ^f   Oshima, Tadayuki ^f   Fujiyama, Yoshihide ^g   Fujiwara, Yasuhiro ^h   Adachi, Kyoichi ^b   Furuta, Kenji ^b   Miki, Masaharu ^b   Azumi, Takane ^b   Shimatani, Tomohiko ⁱ   Inoue, Masaki ⁱ   Tanaka, Shinji ⁱ   Manabe, Noriaki ⁱ   Ueno, Yoshitaka ⁱ   Yoshida, Shigeto ⁱ   Hiyama, Toru ⁱ   Oka, Shiro ⁱ   Ito, Masanori ⁱ   Yoshida, Tomoharu ^j   Ryozawa, Shomei ^j   Yurino, Nobuo ^k   Kyoyama, Yasunori ^k   Kabemura, Teppei ^l   Ochiai, Toshiaki ^l   Yoshimura, Daisuke ^l   Itoyama, Takahiro ^m   Omori, Keizo ^m   Fujimoto, Kazuma ⁿ   Sakata, Hiroyuki ⁿ   more..

^a SAISEIKAI NAKATSU HOSPITAL   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

^d NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^h OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^j YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k Shinyukuhashi Hospital   (Japan)

^l SAISEIKAI FUKUOKA GENERAL HOSPITAL   (Japan)

^m FUKUOKA WAJIRO HOSPITAL   (Japan)

ⁿ SAGA UNIVERSITY   (Japan)

more..

Author keywords

24 hour esophageal pH monitoring; Minimal changes; Nonerosive reflux disease; Rabeprazole

Indexed keywords

RABEPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; ESOPHAGEAL PH MONITORING; FEMALE; HEARTBURN; HUMAN; JAPAN; MALE; MULTICENTER STUDY; NON EROSIVE REFLUX DISEASE; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960967283     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1583-4     Document Type: Article

References (28)

1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-1920.
2. Fass R. Erosive Esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007;41:131-137. (Pubitemid 46148652)
3. Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98:S2-S7. (Pubitemid 36348509)
4. Quigley EM, Hungin AP. Review article: quality of life issues in gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2005;22:41-47. (Pubitemid 41153078)
5. Okamoto K, Iwakiri R, Mori M, et al. Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig Dis Sci. 2003;48:2237-2241. (Pubitemid 38021725)
6. Mishima I, Adachi K, Arima N, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005;40:1005-1009. (Pubitemid 41291347)
7. Galmiche JP. Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results. Drugs. 2006;66:7-13.
8. van Pinxteren B, Numans ME, Bonis PA, et al. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2004;4:CD002095.
9. Fock KM, Teo EK, Ang TL, et al. Rabeprazole vs. esomeprazole in non-erosive gastroesophageal reflux disease: a randomized, double-blind study in urban Asia. World J Gastroenterol. 2005;11:3091-3098. (Pubitemid 40790669)
10. Adachi K, Hashimoto T, Hamamoto N, et al. Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole. J Gastroenterol Hepatol. 2003;18:1392-1398. (Pubitemid 38045853)
11. Robinson M, Fitzgerald S, Hegedus R, et al. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther. 2002;16:445-454. (Pubitemid 34214523)
12. Holtmann G, Bytzer P, Metz M, et al. A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002;16:479-485. (Pubitemid 34214527)
13. Miner P. Relief of symptoms in gastric acid-related diseases-correlation with acid suppression in rabeprazole treatment. Aliment Pharmacol Ther. 2004;20:20-29. (Pubitemid 39593284)
14. Miner P Jr, Orr W, Filippone J, et al. Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Am J Gastroenterol. 2002;97:1332-1339. (Pubitemid 34664773)
15. Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterol. 1996;110:1982-1996.
16. Katz PO. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2006;23:3-11.
17. Hoshihara Y. Endoscopic findings of GERD. Nippon Rinsho. 2004;62:1459-1464.
18. Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol. 2006;41:95-99.
19. Joh T, Miwa H, Higuchi K, et al. Validity of endoscopic classification of nonerosive reflux disease. J Gastroenterol. 2007;42:444-449. (Pubitemid 47050006)
20. Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358-361.
21. Johnston BT, McFarland RJ, Collins JS, et al. Symptom index as a marker of gastro-oesophageal reflux disease. Br J Surg. 1992;79:1054-1055.
22. Kahrilas PJ. Diagnosis of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98:S15-S23. (Pubitemid 36348511)
23. Kasapidis P, Xynos E, Mantides A, et al. Differences in manometry and 24-H ambulatory pH-metry between patients with and without endoscopic or histological esophagitis in gastroesophageal reflux disease. Am J Gastroenterol. 1993;88:1893-1899. (Pubitemid 23324406)
24. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology. 1996;111:1192-1199. (Pubitemid 26362243)
25. Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD) -acid reflux and symptom patterns. Aliment Pharmacol Ther. 2003;17:537-545. (Pubitemid 36384812)
26. Miwa H, Minoo T, Hojo M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2004;20:112-117. (Pubitemid 39120282)
27. Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997;32:974-979. (Pubitemid 27433659)
28. Miwa H, Sasaki M, Furuta T, et al. Efficacy of proton pump inhibitor, rabeprazole, on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan. Aliment Pharmacol Ther. 2007;26:69-77. (Pubitemid 46889840)